First Command Financial Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
BC
First Command Financial Services's XBI Position: Q4 2021 in Review
First Command Financial Services sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2021, closing a stake of 138 shares — an estimated $17K sold.
First Command Financial Services first reported a position in XBI in Q4 2016 and held it in 6 quarters. The position peaked at $19K in Q2 2021. 700 funds tracked by Wall St. Rank hold XBI as of Q4 2021.
- First Command Financial Services reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2021 after selling out during the quarter.
- First Command Financial Services sold 138 State Street SPDR S&P Biotech ETF shares in Q4 2021, an estimated $17K.
- First Command Financial Services first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and held it in 6 quarters.
- First Command Financial Services's State Street SPDR S&P Biotech ETF position peaked at $19K in Q2 2021.
- 700 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2021.
Based on First Command Financial Services's 13F filing for Q4 2021, filed 25 Jan 2022.